Table 2. Numbers of important SNPs used by pan-cancer MTL to estimate PRS of prevalent cancers.
| FDR levels | 0.1% | 5.0% |
|---|---|---|
| Disease | ||
| Malignant melanoma | 48 | 59350 |
| Non-melanoma skin cancer | 132 | 48848 |
| Skin cancer | 106 | 48419 |
| Lung cancer | 4 | 41075 |
| Intrathoracic cancer | 3 | 40392 |
| Colorectal cancer | 36 | 45450 |
| Colon cancer | 22 | 37487 |
| Rectal cancer | 28 | 47904 |
| Bladder cancer | 8 | 37 |
| Uterine cancer | 25 | 38474 |
| Cervical cancer | 5 | 42068 |
| Prostate cancer | 23 | 94 |
| Breast cancer | 34 | 96 |
| Female genital tract cancer | 15 | 37083 |
| Male genital tract cancer | 5 | 40742 |
| Lymphoma | 0 | 43412 |
| Non-hodgkins lymphoma | 4 | 41889 |